Europe — EMA

Olmesartan+hctz Sandoz (Olmesartan Medoxomil, Hydrochlorothiazide)

Olmesartan medoxil, the active ingredient in Olmesartan+hctz Sandoz, is an angiotensin II receptor blocker presented as a tablet for oral use.

Olmesartan Medoxomil, Hydrochlorothiazide

Request sourcing

Pack/s

What is Olmesartan Medoxomil, Hydrochlorothiazide?

Olmesartan medoxil, the active ingredient in Olmesartan+hctz Sandoz, is an angiotensin II receptor blocker presented as a tablet for oral use. It treats hypertension, often in combination with a diuretic, and is intended for adult patients. GNH USA supplies Olmesartan+hctz Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Olmesartan+hctz Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

What is Olmesartan Medoxomil, Hydrochlorothiazide used for?

Olmesartan+hctz Sandoz is an antihypertensive medication that works within the renin‑angiotensin‑aldosterone system to lower blood pressure. - Hypertension: Improves blood‑pressure control in patients with primary high risk hypertension. - Heart failure: Assists y t ? t ? - Chronic kidney g g - t - -

What are the side effects of Olmesartan Medoxomil, Hydrochlorothiazide?

Common t ewline ...

...

What precautions apply to Olmesartan Medoxomil, Hydrochlorothiazide?

...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →